Insider · CIK 0001519692

Greenstein Leonard M.

Reports to the SEC for 3 companies · CARLSBAD, CA

sec.gov

Transactions

Companies

Filings

CIK

0001519692

Forms 4 and 5

Insider transactions

34 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-01-28	CARLCARLSMED, INC.A Award	CFO, Treasurer	AAward	+45K sh	—	—	188,346
2025-07-22	CARLCARLSMED, INC. · Stock Options (Right to Buy)A Award	CFO, Treasurer	AAward	+71.4K sh	—	—	155,102
2023-04-20	TARSTarsus Pharmaceuticals, Inc.S Sale	Chief Financial Officer	SSale	−5,000 sh	$14.02	−$70.1K	26,785
2023-03-23	TARSTarsus Pharmaceuticals, Inc.S Sale	Chief Financial Officer	SSale	−346 sh	$12.15	−$4,203.9	31,785
2023-03-22	TARSTarsus Pharmaceuticals, Inc.S Sale	Chief Financial Officer	SSale	−332 sh	$12.64	−$4,196.48	32,131
2023-03-21	TARSTarsus Pharmaceuticals, Inc.S Sale	Chief Financial Officer	SSale	−326 sh	$12.89	−$4,202.14	32,463
2023-03-20	TARSTarsus Pharmaceuticals, Inc.S Sale	Chief Financial Officer	SSale	−333 sh	$12.61	−$4,199.13	32,789
2023-03-17	TARSTarsus Pharmaceuticals, Inc.S Sale	Chief Financial Officer	SSale	−316 sh	$13.28	−$4,196.48	33,122
2023-03-16	TARSTarsus Pharmaceuticals, Inc.S Sale	Chief Financial Officer	SSale	−313 sh	$13.43	−$4,203.59	38,438
2023-03-16	TARSTarsus Pharmaceuticals, Inc.S Sale	Chief Financial Officer	SSale	−5,000 sh	$13.44	−$67.2K	33,438
2023-03-15	TARSTarsus Pharmaceuticals, Inc. · Restricted Stock UnitsM Exercise/Conversion	Chief Financial Officer	MExercise/Conversion	−4,462 sh	—	—	13,388
2023-03-15	TARSTarsus Pharmaceuticals, Inc.M Exercise/Conversion	Chief Financial Officer	MExercise/Conversion	+4,462 sh	—	—	38,751
2023-03-08	TARSTarsus Pharmaceuticals, Inc. · Stock Option (right to buy)A Award	Chief Financial Officer	AAward	+40.1K sh	—	—	40,097
2023-03-08	TARSTarsus Pharmaceuticals, Inc. · Restricted Stock UnitsA Award	Chief Financial Officer	AAward	+27.2K sh	—	—	27,160
2023-02-16	TARSTarsus Pharmaceuticals, Inc.S Sale	Chief Financial Officer	SSale	−5,000 sh	$15.12	−$75.6K	34,289
2023-01-19	TARSTarsus Pharmaceuticals, Inc.S Sale	Chief Financial Officer	SSale	−5,000 sh	$14.56	−$72.8K	39,289
2022-12-15	TARSTarsus Pharmaceuticals, Inc.S Sale	Chief Financial Officer	SSale	−5,000 sh	$14.64	−$73.2K	44,289
2022-11-17	TARSTarsus Pharmaceuticals, Inc.S Sale	Chief Financial Officer	SSale	−5,000 sh	$16.54	−$82.7K	49,289
2022-10-20	TARSTarsus Pharmaceuticals, Inc.S Sale	Chief Financial Officer	SSale	−123 sh	$16.62	−$2,044.26	54,289
2022-10-20	TARSTarsus Pharmaceuticals, Inc.S Sale	Chief Financial Officer	SSale	−4,877 sh	$15.90	−$77.5K	54,412
2022-09-15	TARSTarsus Pharmaceuticals, Inc.S Sale	Chief Financial Officer	SSale	−5,000 sh	$16.03	−$80.2K	59,289
2022-08-18	TARSTarsus Pharmaceuticals, Inc.S Sale	Chief Financial Officer	SSale	−5,000 sh	$16.30	−$81.5K	64,289
2022-03-09	TARSTarsus Pharmaceuticals, Inc. · Stock Option (right to buy)A Award	Chief Financial Officer	AAward	+60.8K sh	—	—	60,846
2022-03-09	TARSTarsus Pharmaceuticals, Inc. · Restricted Stock UnitsA Award	Chief Financial Officer	AAward	+17.9K sh	—	—	17,850
2021-01-07	TARSTarsus Pharmaceuticals, Inc. · Stock Option (right to buy)A Award	Chief Financial Officer	AAward	+41K sh	—	—	40,999
2013-10-03	ENDOLOGIX INC /DE/Option to purchaseD Disposition to Issuer	VP Finance & Corp Controller	DDisposition to Issuer	−4,750 sh	—	—	7,250
2013-10-03	ENDOLOGIX INC /DE/Option to purchaseD Disposition to Issuer	VP Finance & Corp Controller	DDisposition to Issuer	−13.1K sh	—	—	19,938
2013-10-03	ENDOLOGIX INC /DE/D Disposition to Issuer	VP Finance & Corp Controller	DDisposition to Issuer	−14.5K sh	—	—	1,330
2013-09-05	ENDOLOGIX INC /DE/D Disposition to Issuer	VP Finance & Corp Controller	DDisposition to Issuer	−1,973 sh	$16.17	−$31.9K	15,802
2013-05-28	ENDOLOGIX INC /DE/S Sale	VP Finance & Corp Controller	SSale	−1,253 sh	$14.01	−$17.6K	16,445
2012-09-09	ENDOLOGIX INC /DE/A Award	VP Finance & Corp Controller	AAward	+14.5K sh	$13.82	+$200K	17,108
2012-09-09	ENDOLOGIX INC /DE/A Award	VP Finance & Corp Controller	AAward	+14.5K sh	$12.62	+$183K	17,108
2012-09-09	ENDOLOGIX INC /DE/A Award	VP Finance & Corp Controller	AAward	+14.5K sh	$12.62	+$183K	17,108
2011-05-02	ENDOLOGIX INC /DE/Option to purchaseA Award	VP Finance & Corp Controller	AAward	+45K sh	—	—	45,000

Recent filings

Accepted (ET)
Jan 304
Greenstein Leonard M.0001193125-26-032069
SEC(opens sec.gov)
Jul 244
Greenstein Leonard M.0000950170-25-098531
SEC(opens sec.gov)
Apr 214
Greenstein Leonard M.0001519692-23-000012
SEC(opens sec.gov)
Mar 234
Greenstein Leonard M.0001519692-23-000010
SEC(opens sec.gov)
Mar 214
Greenstein Leonard M.0001519692-23-000008
SEC(opens sec.gov)
Mar 174
Greenstein Leonard M.0001519692-23-000006
SEC(opens sec.gov)
Mar 104
Greenstein Leonard M.0001209191-23-017998
SEC(opens sec.gov)
Feb 174
Greenstein Leonard M.0001519692-23-000004
SEC(opens sec.gov)
Jan 204
Greenstein Leonard M.0001519692-23-000002
SEC(opens sec.gov)
Dec 164
Greenstein Leonard M.0001519692-22-000012
SEC(opens sec.gov)
Nov 184
Greenstein Leonard M.0001519692-22-000010
SEC(opens sec.gov)
Oct 284
Greenstein Leonard M.0001519692-22-000008
SEC(opens sec.gov)

Companies

Address

C/O CARLSMED, INC. 1800 ASTON AVE., SUITE 100

CARLSBAD, CA, 92008